Lanean...
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer that lacks ER/PR and HER2 receptors. Hence, there is urgency in developing new or novel therapeutic strategies for treatment of TNBC. Our study shows that the Monocyte Chemoattractant Protein-1 (MCP-1) is a...
Gorde:
| Argitaratua izan da: | Breast Cancer Res Treat |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6022526/ https://ncbi.nlm.nih.gov/pubmed/29594759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4760-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|